References
- Anderson M J, Higgins P G, Davis L R, Willman J S, Jones S E, Kidd I M, Pattision J R, Tyrrell D AJ. Experimental parvoviral infection in humans. J Infect Dis 1985; 152: 257–265
- Mortimer P P, Luban N LC, Kelleher J F, Cohen B J. Transmission of serum parvovirus like virus by clotting factor concentrates. Lancet 1983; 2: 482–484
- Evensen S A, Ulstrup J, Skaug K, Frøland S S, Glomstein A, Rollag H. HIV‐infection in Norwegian haemophiliacs: The prevalence of antibodies against HIV in haemophiliacs treated with lyophilized cryoprecipitate. Eur J Haematol 1987; 39: 44–48
- Rollag H, Evensen S A, Fröland S S, Glomstein A. Serological markers of hepatitis B virus and cytomegalovirus in Norwegians with coagulation factor defects. Blut 1990; 60: 93–96
- Rollag H, Evensen S A, Fröland S S, Glomstein A. Anti‐HCV antibodies among Norwegians with congenital coagulation factor defects treated with plasma products from small pools. Eur J Clin Microbiol Infect Dis 1990; 9: 612–614
- Cohen B J, Mortimer P P, Pereira M S. Diagnostic assays with monoclonal antibodies for the human serum parvovirus‐like virus (SPLV). J Hyg 1983; 91: 113–130
- Anderson M J, Pattison J R. The human parvovirus. A brief review. Arch Virol 1984; 82: 137–144
- Corsi O B, Azzi A, Morfini M, Franci R, Ferrini P R. Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates. J Med Virol 1988; 25: 165–170